[
  {
    "ts": "2025-12-24T22:46:26+00:00",
    "headline": "Weight-loss pill approval spurs food industry overhaul",
    "summary": "<body><p>STORY: Packaged food makers and fast-food chains could be forced to overhaul more of their products next year as a newly-approved weight-loss pill hits the market.</p><p>That's according to food industry analysts who spoke to Reuters.</p><p>The U.S. Food and Drug Administration approved Novo Nordisk's Wegovy GLP-1 pill on Monday, sending shares of food companies down on Tuesday.</p><p>Eli Lilly's rival medication is expected to gain approval from regulators next year.</p><p>Up until now, GLP-1 medications have only been available in injectible form.</p><p>More Americans are expected to try the drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.</p><p>Food companies including Conagra Brands and Nestle are already dealing with shifts in consumer tastes toward higher protein and smaller portions due to the popularity of weight-loss injections.&nbsp;</p><p>Earlier this year, Conagra started labeling some of its Healthy Choice frozen meals with high protein and fiber as, quote, \"GLP-1 friendly.\"&nbsp;</p><p>Nestle, the world's biggest food company, has also introduced new frozen meals that cater specifically to GLP-1 users, called Vital Pursuit.&nbsp;</p><p>Some 40% of American adults are obese, U.S. government data shows, and around 12% of adults say they currently take GLP-1 drugs, according to a poll published last month by health policy research organization KFF.</p></body>",
    "url": "https://finance.yahoo.com/video/weight-loss-pill-approval-spurs-224626785.html",
    "source": "Reuters Videos",
    "provider": "yfinance",
    "raw": {
      "id": "d646d17f-65d4-3c5b-943a-6814d905b8c6",
      "content": {
        "id": "d646d17f-65d4-3c5b-943a-6814d905b8c6",
        "contentType": "VIDEO",
        "title": "Weight-loss pill approval spurs food industry overhaul",
        "description": "<title><body><p>STORY: Packaged food makers and fast-food chains could be forced to overhaul more of their products next year as a newly-approved weight-loss pill hits the market.</p><p>That's according to food industry analysts who spoke to Reuters.</p><p>The U.S. Food and Drug Administration approved Novo Nordisk's Wegovy GLP-1 pill on Monday, sending shares of food companies down on Tuesday.</p><p>Eli Lilly's rival medication is expected to gain approval from regulators next year.</p><p>Up until now, GLP-1 medications have only been available in injectible form.</p><p>More Americans are expected to try the drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.</p><p>Food companies including Conagra Brands and Nestle are already dealing with shifts in consumer tastes toward higher protein and smaller portions due to the popularity of weight-loss injections. </p><p>Earlier this year, Conagra started labeling some of its Healthy Choice frozen meals with high protein and fiber as, quote, \"GLP-1 friendly.\" </p><p>Nestle, the world's biggest food company, has also introduced new frozen meals that cater specifically to GLP-1 users, called Vital Pursuit. </p><p>Some 40% of American adults are obese, U.S. government data shows, and around 12% of adults say they currently take GLP-1 drugs, according to a poll published last month by health policy research organization KFF.</p></body></title>",
        "summary": "<body><p>STORY: Packaged food makers and fast-food chains could be forced to overhaul more of their products next year as a newly-approved weight-loss pill hits the market.</p><p>That's according to food industry analysts who spoke to Reuters.</p><p>The U.S. Food and Drug Administration approved Novo Nordisk's Wegovy GLP-1 pill on Monday, sending shares of food companies down on Tuesday.</p><p>Eli Lilly's rival medication is expected to gain approval from regulators next year.</p><p>Up until now, GLP-1 medications have only been available in injectible form.</p><p>More Americans are expected to try the drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.</p><p>Food companies including Conagra Brands and Nestle are already dealing with shifts in consumer tastes toward higher protein and smaller portions due to the popularity of weight-loss injections.&nbsp;</p><p>Earlier this year, Conagra started labeling some of its Healthy Choice frozen meals with high protein and fiber as, quote, \"GLP-1 friendly.\"&nbsp;</p><p>Nestle, the world's biggest food company, has also introduced new frozen meals that cater specifically to GLP-1 users, called Vital Pursuit.&nbsp;</p><p>Some 40% of American adults are obese, U.S. government data shows, and around 12% of adults say they currently take GLP-1 drugs, according to a poll published last month by health policy research organization KFF.</p></body>",
        "pubDate": "2025-12-24T22:46:26Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/uu/api/res/1.2/w0vtQcB.rZFJjC9OXVGG0A--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/1fc41f78-8369-4cf5-a84a-f963ac6d0b46/main/1280x720/52s430ms/match/image.jpg",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7Lk92vEuHL6lvCuYauOPug--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/1fc41f78-8369-4cf5-a84a-f963ac6d0b46/main/1280x720/52s430ms/match/image.jpg.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hNO.k4ZT3_8njg_lTA8lhw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/1fc41f78-8369-4cf5-a84a-f963ac6d0b46/main/1280x720/52s430ms/match/image.jpg.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters Videos",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/weight-loss-pill-approval-spurs-224626785.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/weight-loss-pill-approval-spurs-224626785.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NSRGF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "CAG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]